Hologic Inc (HOLX): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Hologic ( HOLX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.6%. By the end of trading, Hologic fell $1.14 (-5.2%) to $20.54 on heavy volume. Throughout the day, 10,226,256 shares of Hologic exchanged hands as compared to its average daily volume of 3,278,700 shares. The stock ranged in price between $20.33-$21.80 after having opened the day at $21.77 as compared to the previous trading day's close of $21.67. Other companies within the Health Care sector that declined today were: Neurocrine Biosciences ( NBIX), down 29.7%, Chemocentryx ( CCXI), down 24.3%, IMRIS ( IMRS), down 9.3% and SunLink Health Systems ( SSY), down 8.7%.

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. Hologic has a market cap of $5.8 billion and is part of the health services industry. Shares are up 6.9% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Hologic as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, NanoString Technologies ( NSTG), up 70.6%, GW Pharmaceuticals PLC ADR ( GWPH), up 53.9%, XenoPort ( XNPT), up 17.1% and Galectin Therapeutics ( GALT), up 15.3% , were all gainers within the health care sector with Baxter International ( BAX) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Hologic Looks Good on the Charts

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers

Cramer: These Sectors Look Bullish (Part III)